Transdermal Drug Delivery Devices are the medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. GlobalData's Medical Devices sector report, “Transdermal Drug Delivery Devices – Medical Devices Pipeline Assessment, 2019" provides comprehensive information about the Transdermal Drug Delivery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
The Transdermal Drug Delivery Devices Pipeline Assessment report provides key information and data related to:
Extensive coverage of the Transdermal Drug Delivery Devices under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Transdermal Drug Delivery Devices pipeline products.
Review of Recent Developments in the segment / industry
The Transdermal Drug Delivery Devices Pipeline Assessment report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Transdermal Drug Delivery Devices under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2009 and forecast to 2023
• 4,500+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape
• 56,000+ medical equipment company profiles
• 4,300+ company profiles of medical equipment manufacturers in China and India
• 2,000+ company profiles of medical equipment manufacturers in Japan
• 825+ companies’ revenue splits and market shares
• 1,900+ quarterly and annual medical equipment company financials
• 940+ medical equipment company SWOTs
• 21,500+ pipeline product profiles
• 34,500+ marketed product profiles
• 36,000+ clinical trials
• 36,500+ trial investigators
• 5,400+ reports on companies with products in development
• 33,000+ deals in the medical equipment industry
• 1,300+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.
Scope
– Extensive coverage of the Transdermal Drug Delivery Devices under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Transdermal Drug Delivery Devices and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry
Reasons to buy
The report enables you to:
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Transdermal Drug Delivery Devices under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date
'
1 Table of Contents 2
1.1 List of Tables 14
1.2 List of Figures 25
2 Introduction 26
2.1 Transdermal Drug Delivery Devices Overview 26
3 Products under Development 27
3.1 Transdermal Drug Delivery Devices – Pipeline Products by Stage of Development 27
3.2 Transdermal Drug Delivery Devices – Pipeline Products by Segment 28
3.3 Transdermal Drug Delivery Devices – Pipeline Products by Territory 29
3.4 Transdermal Drug Delivery Devices – Pipeline Products by Regulatory Path 31
3.5 Transdermal Drug Delivery Devices – Pipeline Products by Estimated Approval Date 32
3.6 Transdermal Drug Delivery Devices – Ongoing Clinical Trials 33
4 Transdermal Drug Delivery Devices – Pipeline Products under Development by Companies 34
4.1 Transdermal Drug Delivery Devices Companies – Pipeline Products by Stage of Development 34
4.2 Transdermal Drug Delivery Devices – Pipeline Products by Stage of Development 39
5 Transdermal Drug Delivery Devices Companies and Product Overview 45
5.1 3M Co Company Overview 45
5.1.1 3M Co Pipeline Products & Ongoing Clinical Trials Overview 45
5.2 4P Therapeutics LLC Company Overview 47
5.2.1 4P Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 47
5.3 Actuated Medical Inc Company Overview 52
5.3.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 52
5.4 Aequus Pharmaceuticals Inc Company Overview 53
5.4.1 Aequus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 53
5.5 Agile Therapeutics Inc Company Overview 59
5.5.1 Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 59
5.6 Allergan Plc Company Overview 65
5.6.1 Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview 65
5.7 Alliqua BioMedical Inc Company Overview 67
5.7.1 Alliqua BioMedical Inc Pipeline Products & Ongoing Clinical Trials Overview 67
5.8 AMW GmbH Company Overview 68
5.8.1 AMW GmbH Pipeline Products & Ongoing Clinical Trials Overview 68
5.9 AngioSoma Inc Company Overview 70
5.9.1 AngioSoma Inc Pipeline Products & Ongoing Clinical Trials Overview 70
5.10 Apogee Technology Inc Company Overview 71
5.10.1 Apogee Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 71
5.11 Asahi Kasei Pharma Corp Company Overview 72
5.11.1 Asahi Kasei Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview 72
5.12 AstraZeneca Plc Company Overview 73
5.12.1 AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview 73
5.13 Avro Life Sciences Company Overview 76
5.13.1 Avro Life Sciences Pipeline Products & Ongoing Clinical Trials Overview 76
5.14 Boryung Pharmaceutical Co Ltd Company Overview 77
5.14.1 Boryung Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 77
5.15 Burke Pharmaceuticals LLC Company Overview 78
5.15.1 Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview 78
5.16 Cassava Sciences Inc Company Overview 80
5.16.1 Cassava Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 80
5.17 CB Scientific Inc Company Overview 81
5.17.1 CB Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 81
5.18 Cerimon Pharmaceuticals, Inc. (Inactive) Company Overview 82
5.18.1 Cerimon Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 82
5.19 ChemioCare USA Inc Company Overview 83
5.19.1 ChemioCare USA Inc Pipeline Products & Ongoing Clinical Trials Overview 83
5.20 Chrono Therapeutics Inc Company Overview 88
5.20.1 Chrono Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 88
5.21 Cipla Ltd Company Overview 89
5.21.1 Cipla Ltd Pipeline Products & Ongoing Clinical Trials Overview 89
5.22 Clexio Biosciences Ltd Company Overview 90
5.22.1 Clexio Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 90
5.23 Corium International Inc Company Overview 91
5.23.1 Corium International Inc Pipeline Products & Ongoing Clinical Trials Overview 91
5.24 Daewoong Pharmaceutical Co Ltd Company Overview 98
5.24.1 Daewoong Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 98
5.25 DBV Technologies SA Company Overview 99
5.25.1 DBV Technologies SA Pipeline Products & Ongoing Clinical Trials Overview 99
5.26 DD Therapeutics LLC Company Overview 103
5.26.1 DD Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 103
5.27 Dermisonics Inc (Inactive) Company Overview 104
5.27.1 Dermisonics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 104
5.28 Dharma Therapeutics, Inc. (Inactive) Company Overview 105
5.28.1 Dharma Therapeutics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 105
5.29 Drexel University Company Overview 106
5.29.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 106
5.30 DURECT Corp Company Overview 107
5.30.1 DURECT Corp Pipeline Products & Ongoing Clinical Trials Overview 107
5.31 Echo Therapeutics Inc Company Overview 109
5.31.1 Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 109
5.32 Emplicure AB Company Overview 110
5.32.1 Emplicure AB Pipeline Products & Ongoing Clinical Trials Overview 110
5.33 Endo International Plc Company Overview 111
5.33.1 Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview 111
5.34 Extend Biosciences Inc Company Overview 112
5.34.1 Extend Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 112
5.35 Fe3 Medical Inc Company Overview 113
5.35.1 Fe3 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 113
5.36 Georgia Institute of Technology Company Overview 114
5.36.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 114
5.37 Georgia State University Company Overview 117
5.37.1 Georgia State University Pipeline Products & Ongoing Clinical Trials Overview 117
5.38 Hisamitsu Pharmaceutical Co Inc Company Overview 118
5.38.1 Hisamitsu Pharmaceutical Co Inc Pipeline Products & Ongoing Clinical Trials Overview 118
5.39 I.M. Sechenov Moscow State Medical University Company Overview 125
5.39.1 I.M. Sechenov Moscow State Medical University Pipeline Products & Ongoing Clinical Trials Overview 125
5.40 Icure Pharmaceutical Inc Company Overview 126
5.40.1 Icure Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview 126
5.41 ImmuPatch Company Overview 129
5.41.1 ImmuPatch Pipeline Products & Ongoing Clinical Trials Overview 129
5.42 Indian Institute of Science Company Overview 131
5.42.1 Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview 131
5.43 Indian Institute of Technology Bombay Company Overview 132
5.43.1 Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 132
5.44 InMed Pharmaceuticals Inc Company Overview 133
5.44.1 InMed Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 133
5.45 Institute of Materials Research & Engineering Company Overview 134
5.45.1 Institute of Materials Research & Engineering Pipeline Products & Ongoing Clinical Trials Overview 134
5.46 Intercell AG (Inactive) Company Overview 135
6.250 May 10, 2018: Nuvo Pharmaceuticals Announces Director Election Results of its Annual General Meeting 542
6.251 May 09, 2018: 3M Announces New Leadership Appointment 542
6.252 May 09, 2018: Revance Therapeutics Announces Two Recent Additions to Its Management Team 542
6.253 May 09, 2018: Simon Dingemans, Chief Financial Officer, to retire from GSK 543
6.254 May 08, 2018: DBV Technologies to Present New Clinical Data from Viaskin Platform at the 2018 EAACI Meeting 544
6.255 May 08, 2018: Revance Releases First Quarter 2018 Results 546
6.256 May 08, 2018: Antares Pharma Reports First Quarter 2018 Operating and Financial Results 547
6.257 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 548
6.258 May 07, 2018: Agile Therapeutics Announces First Quarter 2018 Financial Results 549
6.259 May 07, 2018: Lannett Announces Fiscal 2018 Third-Quarter Financial Results 550
7 Appendix 552
7.1 Methodology 552
7.2 About GlobalData 555
7.3 Contact Us 555
7.4 Disclaimer 555
